Scientists Create Heart Pacemaker Cells That Could Replace Electronic Devices

Heart rhythm disorders affect millions worldwide, often requiring electronic pacemakers that come with significant drawbacks including infection risk, battery replacement surgeries, and limited lifespan. This groundbreaking study offers a biological alternative that could revolutionize cardiac care.

Researchers at the University Health Network developed a method to create atrioventricular node-like pacemaker cells (AVNLPCs) from human pluripotent stem cells. The atrioventricular node is the heart's natural electrical bridge that coordinates contractions between the upper and lower chambers.

Using precise molecular signaling techniques, scientists guided stem cells to differentiate into cells that closely resembled fetal heart pacemaker cells. These lab-grown cells demonstrated proper electrical properties and pacemaker function in laboratory tests.

Most importantly, when transplanted into guinea pig hearts with induced rhythm disorders, these biological pacemaker cells successfully restored normal heart function. The cells integrated into the heart tissue and maintained their pacemaker activity, effectively creating a "biological conduction bridge."

This advancement could transform treatment for atrioventricular block, a potentially fatal condition where electrical signals between heart chambers are disrupted. Unlike electronic pacemakers, biological alternatives wouldn't require battery changes, could grow with pediatric patients, and might reduce long-term complications. The research represents a significant step toward regenerative cardiac therapies that could improve outcomes for heart disease patients while potentially extending healthy lifespan by providing more durable, natural heart rhythm solutions.